WOBURN, Mass.--(BUSINESS WIRE)--Spear Bio, a biotechnology company pioneering homogeneous ultrasensitive immunoassay technology, is pleased to announce a strategic distribution partnership with ...
Barchart on MSN
Are Wall Street analysts bullish on Bio-Techne stock?
With a market cap of $7.5 billion, Bio-Techne Corporation (TECH) is a global life sciences company that develops, ...
Personal health and wellness is one of the many secular tailwinds for healthcare companies. But financial performance has ...
Hollow Brook Wealth Management sold its entire position in Bio-Techne -- 174,677 shares -- during the fourth quarter of 2025, for an estimated $10.7 million based on quarterly average pricing. The ...
View Bio-Techne Corporation TECH stock quote prices, financial information, real-time forecasts, and company news from CNN.
Shares of Bio-Techne Corp. slid 5.34% to $44.89 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index rising 0.58% to 7,444.25 and the Dow ...
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.
New SPYRE™ Focus Panels (Stroma and Vessel) broaden modular panel options, enabling deeper targeted insights in spatial biology workflows. SPYRE™ Amplification Kits leverage sequential and enhanced ...
RBC Capital on Tuesday upgraded Bio-Techne Corporation (NASDAQ:TECH), noting that recent end-market weakness has over-penalized one of the best assets in the life science and tools (LST) sector, ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results